These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9024217)

  • 21. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood?
    Léger J; Danner S; Simon D; Garel C; Czernichow P
    J Clin Endocrinol Metab; 2005 Feb; 90(2):650-6. PubMed ID: 15546901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women.
    Burman P; Johansson AG; Siegbahn A; Vessby B; Karlsson FA
    J Clin Endocrinol Metab; 1997 Feb; 82(2):550-5. PubMed ID: 9024252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
    Esen I; Demirel F; Tepe D; Kara O; Koc N
    Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M; Salati B; Bianchi S; Rallo M; Tinelli C; Autelli M; Aimaretti G; Ghigo E
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of overweight on effectiveness of treatment with human growth hormone in growth hormone deficient children: analysis of German KIGS data.
    Reinehr T; Bechtold-Dalla Pozza S; Bettendorf M; Doerr HG; Gohlke B; Hauffa BP; Kaspers S; Land C; Mehls O; Schwab KO; Stahnke N; Ranke MB;
    Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):544-8. PubMed ID: 22006181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency.
    Juul A; Holm K; Kastrup KW; Pedersen SA; Michaelsen KF; Scheike T; Rasmussen S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2497-502. PubMed ID: 9253324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in serum GH cut-off values for pharmacological tests of GH secretion depend on the serum GH method. Clinical validation from the growth velocity score during the first year of treatment.
    Chaler EA; Rivarola MA; Guerci B; Ciaccio M; Costanzo M; Travaglino P; Maceiras M; Pagani S; Meazza C; Bozzola E; Barberi S; Bozzola M; Belgorosky A
    Horm Res; 2006; 66(5):231-5. PubMed ID: 16912509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seeking the optimal target range for insulin-like growth factor I during the treatment of adult growth hormone disorders.
    Mukherjee A; Monson JP; Jönsson PJ; Trainer PJ; Shalet SM;
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5865-70. PubMed ID: 14671182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discontinuation of growth hormone (GH) treatment during the transition phase is an important factor determining the phenotype of young adults with nonidiopathic childhood-onset GH deficiency.
    Kołtowska-Häggström M; Geffner ME; Jönsson P; Monson JP; Abs R; Hána V; Höybye C; Wollmann HA
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2646-54. PubMed ID: 20335451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial growth hormone deficiency (GHD) in children has more similarities to idiopathic short stature than to severe GHD.
    Smyczyńska J; Lewiński A; Hilczer M; Stawerska R; Karasek M
    Endokrynol Pol; 2007; 58(3):182-7. PubMed ID: 17940982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is retesting in growth hormone deficient children really useful?
    Meazza C; Gertosio C; Pagani S; Pilotta A; Tinelli C; Buzi F; Farello G; Genoni G; Bona G; Bozzola M
    Minerva Endocrinol; 2017 Dec; 42(4):325-330. PubMed ID: 27304071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability of clonidine testing for the diagnosis of growth hormone deficiency in children and adolescents.
    Ibba A; Guzzetti C; Casula L; Salerno M; Di Iorgi N; Allegri AME; Cappa M; Maghnie M; Loche S
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):765-770. PubMed ID: 30171702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.
    Aimaretti G; Corneli G; Razzore P; Bellone S; Baffoni C; Arvat E; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1998 May; 83(5):1615-8. PubMed ID: 9589665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth Hormone (GH) Therapy During the Transition Period: Should We Think About Early Retesting in Patients with Idiopathic and Isolated GH Deficiency?
    Penta L; Cofini M; Lucchetti L; Zenzeri L; Leonardi A; Lanciotti L; Galeazzi D; Verrotti A; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(3):. PubMed ID: 30678118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.